Betting on Corps.
Desperate for a Cure
In particular, the craziness of forming the company, floating the money to keep the company going, and forming the partnership with the other manufacturer are fantastic facts for creating a sprawling issue spotter. Between the business man and the scientist, we could get a number of great agency questions. What if one promises free medicine to the kids who come in to talk? And how do all the private donations affect the company when it goes public? Are those prior claims? What share of the company do they own? Any? As the semester goes by, I imagine this article could only spawn a thousand more hypotheticals.
Note how well this fits to with Talley's hint that he may ask about ratification, and that funny first element of existence. Ratification by Novazyme cannot occur until it formally exists, even if the scientist and business man are running around making promises. This fact pattern would make it really easy to slip this question in.
So, there you go. You heard it hear first. The story of Novazyme Phamaceuticals will be appearing on the Corporations final. Current odds, 3:1.